Editas Medicine, Inc. - Common Stock (EDIT)

CUSIP: 28106W103

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Shares outstanding
82,773,190
Total 13F shares
45,377,308
Share change
-5,754,381
Total reported value
$862,213,005
Put/Call ratio
124%
Price per share
$19.02
Number of holders
239
Value change
-$137,494,973
Number of buys
106
Number of sells
133

Quarterly Holders Quick Answers

What is CUSIP 28106W103?
CUSIP 28106W103 identifies EDIT - Editas Medicine, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q1 2022

As of 31 Mar 2022, Editas Medicine, Inc. - Common Stock (EDIT) was held by 239 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,377,308 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, Capital World Investors, CREDIT SUISSE AG/, Nikko Asset Management Americas, Inc., and Sumitomo Mitsui Trust Holdings, Inc.. This page lists 239 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.